Core Insights - Ardent Health's fourth-quarter revenue was $1.61 billion, flat year-over-year, but adjusted for prior-year benefits, growth would have been approximately 3% [1] - The company reported a full-year revenue increase of 6% to $6.3 billion, with adjusted EBITDA rising 9% to $545 million [2][5] - The company is experiencing positive developments and operational momentum, with 2025 marking its highest-ever revenue, EBITDA, and operating cash flow [3] Financial Performance - Fourth-quarter admissions increased by 1.5%, with adjusted admissions growing by 2% [1] - For the full year, admissions grew by 5.3% and adjusted admissions by 2.3% [2] - Adjusted EBITDA for the fourth quarter was $134 million, exceeding the company's guidance midpoint by 2% [1] Operational Improvements - The IMPACT operating model transformation is yielding early labor and efficiency gains, with expected annualized savings raised from $40 million to about $55 million [4][6] - Agency labor FTEs were reduced by approximately 175 in the last four months of 2025, and contract labor expenses fell by 26% to $17 million [7] - Operating room performance improved, with first-case on-time starts rising by over 10 percentage points in the fourth quarter [8] Technology and Innovation - The deployment of technology, including a "single instance of Epic," is enhancing efficiency and standardizing workflows [9] - AI-assisted virtual care initiatives are being expanded, with plans to implement AI-enabled scribe technology and medical wearables for continuous monitoring [16] Industry Challenges and Guidance - The company anticipates a revenue range of $6.4 billion to $6.7 billion for 2026, with adjusted EBITDA expected between $485 million and $535 million [4][13] - Management noted a $35 million exchange-related headwind and ongoing high-single-digit growth in professional fees [4][15] - Payer denials and professional fees showed signs of stabilization, with professional fee growth decelerating to 8% in the fourth quarter [11][12] Cash Flow and Future Outlook - Operating cash flow for 2025 rose to $471 million, nearly a 50% increase year-over-year, with free cash flow at $170 million [18] - The company expects a return to adjusted EBITDA growth in 2027 as it laps 2025's headwinds and as IMPACT savings accumulate [17]